Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant

Updated 05/14/2024

Status Withdrawn

Clinical Trial Summary

To investigate the effect of radiotherapy on peripheral blood immune cell composition and function in pediatric malignant brain tumor patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04019470
Study type	Observational
Source	Capital Medical University
Contact
Status	Withdrawn
Phase
Start date	February 1, 2019
Completion date	May 31, 2022

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT03936465` - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer	Phase 1
	Recruiting	`NCT04738162` - Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Supratentorial Brain Tumors	Phase 2
	Not yet recruiting	`NCT06093165` - RE-irradiation of Diffuse MIdline Glioma paTients	N/A
	Recruiting	`NCT05298995` - GD2-CAR T Cells for Pediatric Brain Tumours	Phase 1
	Not yet recruiting	`NCT05553899` - PET-MRI in Paediatric Brain Tumours	N/A
	Recruiting	`NCT05709522` - Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
	Recruiting	`NCT04722237` - Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing	N/A
	Recruiting	`NCT06309251` - Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
	Recruiting	`NCT04670016` - HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
	Active, not recruiting	`NCT03086421` - Social Emotional Development in Young Children With Cancer
	Active, not recruiting	`NCT03361033` - Components of Social Functioning in Survivors of Pediatric Brain Tumors
	Active, not recruiting	`NCT04525014` - RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors	Phase 1
	Recruiting	`NCT05672043` - Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
	Completed	`NCT03871686` - Promotion of Well-being of Young Adult Brain Cancer Survivors	N/A
	Active, not recruiting	`NCT04023669` - Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors	Phase 1
	Suspended	`NCT05169944` - Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors	Phase 1